Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure
February 01, 2023 08:00 ET
|
Miromatrix Medical Inc.
Combines Miromatrix’s expertise in bioengineered organs with Baxter’s leadership in critical care delivery and organ support therapiesIncludes intended Phase I clinical trial designed to generate key...
Miromatrix Provides Update on miroliverELAP
February 01, 2023 07:59 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces FDA Clinical Hold on IND Application for miroliverELAP
December 14, 2022 17:30 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Announces Participation in the Piper Sandler 34th Annual Healthcare Conference
November 21, 2022 07:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix Reports Filing of IND, Third Quarter 2022 Results, and Provides Corporate Update
November 14, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix to Report Third Quarter 2022 Financial Results
November 03, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix CEO Jeff Ross Delivering Keynote Address at ARMI | BioFabUSA 2022 Fall Summit: Meeting in the Millyard
October 19, 2022 07:00 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa
October 05, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
September 26, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...
Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum
September 20, 2022 16:01 ET
|
Miromatrix Medical Inc.
EDEN PRAIRIE, Minn., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs...